ERIN DUM: Open Payments
NPI 1043515018 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,480 in 134 payments from 14 companies in 2025. Trend: 2023 $2,964 · 2024 $2,435 · 2025 $2,480
Food & beverage: $2,367Education: $113
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $458 |
| LEO Pharma Inc. | 13 | $303 |
| ABBVIE INC. | 18 | $285 |
| UCB, Inc. | 17 | $277 |
| GENZYME CORPORATION | 7 | $249 |
| PFIZER INC. | 23 | $218 |
| Novartis Pharmaceuticals Corporation | 11 | $204 |
| Lilly USA, LLC | 13 | $181 |
| Janssen Biotech, Inc. | 6 | $118 |
| Galderma Laboratories, L.P. | 3 | $51 |
Products named: DUPIXENT, Bimzelx, CIBINQO, COSENTYX, TALTZ, ANZUPGO, RINVOQ, SKYRIZI.
Industry payments across OK — which companies pay providers there.
